• 23
    0

    Blueprint Medicines Corp (NASDAQ:BPMC) has reported an insider sale according to the latest SEC filings. Philina Lee, the Chief Commercial Officer of the company, sold 8,023 shares of Blueprint Medicines Corp on March 13, 2024. The transaction was detailed in an SEC Filing made public.Blueprint Medicines Corp is a biopharmaceutical company focused on the discovery, ...